MedPath

SELEGILINE HYDROCHLORIDE

SELEGILINE HYDROCHLORIDE CAPSULES

Approved
Approval ID

dcd786c2-fdf6-46fd-b05f-1618ab6536ab

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 4, 2016

Manufacturers
FDA

Carilion Materials Management

DUNS: 079239644

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

SELEGILINE HYDROCHLORIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68151-2649
Application NumberANDA075352
Product Classification
M
Marketing Category
C73584
G
Generic Name
SELEGILINE HYDROCHLORIDE
Product Specifications
Route of AdministrationORAL
Effective DateJuly 3, 2011
FDA Product Classification

INGREDIENTS (5)

SELEGILINE HYDROCHLORIDEActive
Quantity: 5 mg in 1 1
Code: 6W731X367Q
Classification: ACTIB
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QP
Classification: IACT
LACTOSEInactive
Code: J2B2A4N98G
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SELEGILINE HYDROCHLORIDE - FDA Drug Approval Details